Agencies
Services
Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 24, 2008
| Drug Name | Review Type | Class | Manufacturer |
|---|---|---|---|
| Patanase | New Drug Initial Review | Nasal Preparations � Other | Alcon |
| Requip XL | New Drug Initial Review | Antiparkinson Agents | GlaxoSmithKline |
| Bystolic | New Drug Initial Review | Beta Blocker | Forest |
| Evamist | New Drug Initial Review | Hormone Replacement Therapy | Ther-Rx |
| Zamicet | New Drug Initial Review | Narcotics | Hawthorne |
| Treximet | New Drug Appeal | Triptans � Combination | GlaxoSmithKline |
| Cimzia | New Drug Appeal | Biologic Response Modifiers | UCB |
| Suprax Susp | PDL Appeal | Antibiotics � Cephalosporins | Lupin |
| Symbicort | PDL Appeal | Inhaled Steroids | AstraZeneca |
| Baraclude | PDL Appeal | Hepatitis B Agents | Bristol-Myers Squibb |
| Vytorin | PDL Appeal | Statin Combination | Merck Schering Plough |